BioMap Launches BioX Initiative to Accelerate Global Life Science Innovation with AI-Driven Protein Design

Jun 26, 2024 18:05 CST Updated 18:05

BioMap

Developer of Innovative Drug R&D Platform

Proteins are the primary bearers of life activities, determining every aspect of our body's functioning, from energy metabolism to disease immunity. Proteins are indispensable "messengers, catalysts, and defenders." In daily life, the emergence of various cutting-edge functional protein products — from food and cosmetics to pharmaceuticals and industrial environmental protection — has accelerated the development of numerous industries and greatly improved the quality of human life and sustainable development.

However, the extremely low success rate of cutting-edge protein design has always been a difficult problem plaguing the industry. Traditional experimental screening methods often require a great deal of time and cost, and it is still very challenging to achieve success in the field of cutting-edge non-natural protein design. Nowadays, with the emergence of generative AI based on large life science models, AI Generated Proteins have become possible, bringing new hope to cutting-edge protein design.

Recently, BioMapAnnouncement of the establishment of the first global bio-computing innovation center in Hong Kong, and the launch of the BioMap Bio-Computing Innovation Acceleration Program — BioMap BioX, aiming to cultivate local scientific and technological innovation teams, attract global scientific and technological innovation teams, start from Hong Kong, China, and help promote the development of the global AI for Life Science ecosystem.

BioMap is dedicated to building large AI models in the field of life sciences, and has constructed the "xTrimo" (The Cross-Modal Transformer Representation of Interactome and Multi-Omics), a cross-modal large model with hundreds of billions of parameters. It is the world's largest language model in the field of life sciences to date, serving hundreds of users, including well-known multinational pharmaceutical companies such as Sanofi.

Based on the foundational large model of life sciences, xTrimo, BioMap, in collaboration with ecosystem developers, has constructed hundreds of state-of-the-art (SOTA) models across fields such as protein structure, antibody function, enzymatic protein catalysis, and cell function. These models are of great significance for advancing research and applications in the life sciences. Meanwhile, leveraging the BioMap AIGP platform (AI Generated Protein Platform), more than ten innovative proteins in cutting-edge fields have been designed, further unlocking the potential of large models and accelerating research in drug design, environmental sustainability, and industrial efficiency.

Open Collaboration to Jointly Promote Innovation in Life Sciences

BioMap Aims to Open Source Its Large-Scale Model with Hundreds of Billions of Parameters and Platform Ecosystem Capabilities to Research Teams and Startups in the Life Sciences Field, Supporting the Transformation of Early-Stage R&D into Marketable Products and Industrial Companies.

We will facePharmaceutical Health, Green Technology, Industrial Innovation, Consumption UpgradeFour major fields, selecting from universities and entrepreneurs, providing BioMap technical support, and helping research or entrepreneurial teams connect with global enterprises and investors in the fields of life sciences and bio-computation, assisting practitioners in the life sciences industry to achieve agile entrepreneurship.

If you are a researcher in the field of cutting-edge life sciences

Hope to explore the underlying biological mechanisms through protein perturbation

If you are a scientist in the protein industry

Hope to design a brand-new protein product

If you are a drug developer on the front lines

Hope to solve the problem of large molecule design with new technology

If you are a young person full of innovative ideas

Hope to use AI to change the world

——Welcome to join our BioX program, let us work together to leverage the power of AI, decipher the language of life, accelerate the transformation of dreams, and benefit sustainable development!

BioX: Unlocking the Infinite Potential of Biological Computing

1. Target Audience

Cross-disciplinary protein molecule design, equipment/sensing/data in the life sciences field, AI/software innovation team
Startups that can accelerate the innovation process through the development and application of AI models

2. Application Method

Zero Threshold: For global scientific research teams and innovative enterprises/institutions
Registration Summary: Submit your registration via this link to participate in the online project review.
Preferred Channel: This program reserves a priority channel for ecosystem partners such as Hong Kong universities and parks, and applications through ecosystem partners can be directly sent to the final review.

3. Selected Project Support Resources

AIGP Platform: A single project can obtain AIGP platform computing power coins worth $200,000 or more.
Biological and IT Services: As required by the project, provide additional biological experiments and additional IT services based on the cost price.
Expert Resources and Training: Professional AI, biology, and IT expert resources and training courses, providing team management, BD business, and financing training according to the needs of startup projects.
International Ecological Network: Assist in对接ing international大companies/scene需求方, arrange DemoDay等活动to deeply understand development需求
Financing Connection: Connect with InnoX's contracted investor resources, and entrepreneurial projects that pass the evaluation can receive investment funds.

4. Early Bird Benefits

For the first 100 registered but unsuccessful projects, BioMap will also provide certain AIGP platform service support and professional training to the registered teams.

BioMap BioX

Scan the code to register and apply now!

https://www.biomap.com/biox/survey

FAQ

Q: What is the project application process?

Answer:Project preliminary screening - Pre-communication - Final communication - Confirmation of cooperation intention - Agreement signing - Resource support, the selection and signing cycle for a single project is within 3 months, with a rolling release.

Q: What can the AIGP platform do?

Answer:AIGP stands for AI Generated Protein, a computational protein design platform built by BioMap. We will provide foundational fine-tuning services based on BioMap's large-scale Foundation Model (xTrimo) with hundreds of billions of parameters, enabling biological scientists to independently develop targeted models to address protein design challenges. Additionally, the platform offers a variety of off-the-shelf protein prediction models and other integrated tools, providing a one-stop solution for researchers' computational protein design needs. For more information,Please visit https://aigp.biomap.com/.

Q: How many projects does BioMap plan to support each year?

Answer:To ensure the support quality of the projects, we will limit the number to less than 50 per year, but will also dynamically adjust based on the application situation.

Q: Who are the current contracted partners of BioMap InnoHub?

Answer:The first batch of projects will be mainly supported by BioMap and connected with BioMap's strategic partners, including Top 20 overseas pharmaceutical companies, top dollar investors, and park resources such as Science Park and Cyberport. We will continue to update the list of contracted partners.

Q: Who is the final jury, and are there any external judges?

Answer:The first batch of projects will mainly be internally reviewed by BioMap executives. External independent judges will also be introduced later, so please stay tuned.

Click to expand, view more content